← Back to Search
Evaluation Of Eudragit-coated Chitosan Microparticles As An Oral Immune Delivery System.
Mika Hori, H. Onishi, Y. Machida
Published 2005 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Chitosan microparticles containing ovalbumin (OVA), OVA-containing chitosan microparticles (Chi-OVA), were prepared, coated with Eudragit L100 (ER), and evaluated as oral vaccine. Chi-OVA with an OVA content of 34.4% (w/w) and a mean particle size of 2.3 microm were used for experiments in vitro and in vivo. ER-coated Chi-OVA (ER-Chi-OVA) contained 3.6-20.5% (w/w) OVA and had a particle size of 47.9-161.1 microm. Chi-OVA dissolved readily in JP 14 first fluid, but not in JP 14 second fluid. The release of OVA from Chi-OVA was suppressed extensively in JP 14 second fluid. ER-Chi-OVA did not dissolve in JP 14 first fluid, and the release of OVA was suppressed greatly in JP 14 first and second fluids. OVA solution, Chi-OVA and ER-Chi-OVA (200 and 800 microg OVA/mouse) were administered to Balb/C mice twice at a 1-week interval. At 7 d after the second administration, plasma OVA-specific IgG and fecal OVA-specific IgA levels were measured. OVA-specific IgG tended to be enhanced in Chi-OVA and ER-Chi-OVA, but was the highest in OVA solution. OVA-specific IgA was induced significantly more efficiently by ER-Chi-OVA than the others. These suggested that ER-Chi-OVA should be possibly useful to induce an intestinal mucosal immune response.
This paper references
Ovalbumin digestion by human pepsins 1, 3 and 5.
V. Walker (1978)
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
T. Uchida (1994)
Transport of Chitosan Microparticles for Mucosal Vaccine Delivery in a Human Intestinal M-cell Model
I. M. van der Lubben (2002)
Towards a multipurpose mucosal vaccination using phosphorylcholine as a unique antigen
S. Trollé (1998)
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
J. Eldridge (1990)
Comparative study of in vitro digestibility of food proteins and effect of preheating on the digestion.
K. Takagi (2003)
Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice.
L. Wikingsson (2002)
Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats.
Junko Takishima (2002)
Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses.
J. Kunisawa (2000)
Dose and Load Studies for Subcutaneous and Oral Delivery of Poly(lactide-co-glycolide) Microspheres Containing Ovalbumin
T. Uchida (2004)
Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
Y. Tabata (1996)
Chitosan and its derivatives in mucosal drug and vaccine delivery.
I. M. van der Lubben (2001)
Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
I. M. van der Lubben (2001)
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
Microparticles as potentially orally active immunological adjuvants.
D. O'hagan (1989)
In Vivo Uptake of Chitosan Microparticles by Murine Peyer's Patches: Visualization Studies using Confocal Laser Scanning Microscopy and Immunohistochemistry
I. M. van der Lubben (2001)
Bioadhesive Characteristics of Chitosan Microspheres to the Mucosa of Rat Small Intestine
J. Shimoda (2001)
Potential efficacy of gelatin microspheres as a new adjuvant for oral vaccination
M. Nakamura (1998)
Investigation of Digestion and Absorption of a Dietary Protein by Using Its Antigenicity as an Index: Gastrointestinal Digestion of Ovalbumin
T. Fushiki (1985)
This paper is referenced by
Chitosan-based systems for the delivery of vaccine antigens
H. C. Arca (2009)
Food protein-based materials as nutraceutical delivery systems
L. Chen (2006)
Emerging Trends in Delivery of Novel Vaccine Formulations
Trinh Vo (2015)
10 – Food-protein-derived materials and their use as carriers and delivery systems for active food components
M. Subirade (2008)
Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review
M. A. Islam (2012)
In vitro evaluation of quaternized polydimethylaminoethylmethacrylate sub-microparticles for oral insulin delivery
T. Sonia (2013)
Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine.
M. L. Guzmán (2012)
Microcapsules formulated in the enteric coating copolymer Eudragit L100 as delivery systems for oral vaccination against infections by gastrointestinal nematode parasites
M. Dea-Ayuela (2006)
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs
Qianwen Li (2017)
Delivery systems and adjuvants for oral vaccines
E. Lavelle (2006)
Chapter 7 – Nanopharmacology
Zoraida P. Aguilar (2013)
Advance in chitosan hydrolysis by non-specific cellulases.
W. Xia (2008)
Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles
Y. López (2014)
In vitro evaluation of N-(2-hydroxy) propyl-3-trimethyl ammonium chitosan for oral insulin delivery
T. A. Sonia (2011)
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).
A. Shukla (2008)
Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
Hesham H. Salman (2009)
Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice
Muye He (2019)
Preparation and In Vitro Characteristics of Lactoferrin-loaded Chitosan Microparticles
H. Onishi (2007)
The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres
N. K. Thakral (2011)
Evaluation of Bioadhesive Capacity and Immunoadjuvant Properties of Vitamin B12-Gantrez Nanoparticles
Hesham H. Salman (2008)
Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles
Pratap C. Naha (2008)
Edwardsiella tarda OmpA Encapsulated in Chitosan Nanoparticles Shows Superior Protection over Inactivated Whole Cell Vaccine in Orally Vaccinated Fringed-Lipped Peninsula Carp (Labeo fimbriatus)
Saurabh Dubey (2016)
Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.
Aurélie Kern (2016)
pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Jishan Quan (2008)
Microparticles for oral delivery and cell encapsulation using membrane emulsification
S. Morelli (2017)
Developments in the formulation and delivery of spray dried vaccines
Gaurav Kanojia (2017)
Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine
M. Pastor (2014)
Chitosan-based mucosal adjuvants: Sunrise on the ocean
Y. Xia (2015)
Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer
N. K. Thakral (2010)
Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases.
B. Singh (2018)
Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.
A. Shukla (2015)
pH‐responsive poly(DMAPMA‐co‐HEMA)‐based hydrogels for prolonged release of 5‐fluorouracil
R. Mishra (2012)See more